Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations

Thorax

Volumn 66, Issue SUPPL. 1, 2011, Pages

  Ahmedzai, S ^a   Balfour Lynn, I M ^b   Bewick, T ^c   Buchdahl, R ^d   Coker, Robina Kate ^e   Cummin, A R ^e   Gradwell, D P ^f   Howard, L ^e   Innes, J A ^g   Johnson, A O C ^h   Lim, E ^b   Lim, Wei Shen ⁱ   McKinlay, K P ^j   Partridge, M R ^k   Popplestone, M ^l   Pozniak, A ^m   Robson, A ^g   Shovlin, C L ^k   Shrikrishna, D ^b   Simonds, A ^b   Tait, P ^o   Thomas, M ⁿ   more..

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^d Hillingdon Hospital NHS Trust   (United Kingdom)

^e IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^f RAF Centre of Aviation Medicine   (United Kingdom)

^g WESTERN GENERAL HOSPITAL   (United Kingdom)

^h Pontefract General Infirmary   (United Kingdom)

ⁱ NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^j NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^k IMPERIAL COLLEGE LONDON   (United Kingdom)

^l Virgin Atlantic   (United Kingdom)

^m CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

ⁿ UK Confidential Reporting Programme for Aviation and Maritime   (United Kingdom)

^o UNIVERSITY OF ABERDEEN   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

AIRBORNE INFECTION; ALTITUDE; ARTIFICIAL HEART PACEMAKER; ARTIFICIAL VENTILATION; ASTHMA; AVIATION; BREATHING DISORDER; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMON COLD; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CORONARY ARTERY DISEASE; CYANOTIC HEART DISEASE; DEFIBRILLATOR; EMERGENCY MEDICINE; EVIDENCE BASED MEDICINE; FORCED EXPIRATORY VOLUME; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; HYPERVENTILATION; HYPOXEMIA; INFLUENZA; INTERSTITIAL LUNG DISEASE; KYPHOSCOLIOSIS; LUNG ABSCESS; LUNG CANCER; MEDICAL SOCIETY; MIDDLE EAR DISEASE; NEUROMUSCULAR DISEASE; OBESITY; OXYGEN THERAPY; PARANASAL SINUS DISEASE; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY ARTERIOVENOUS FISTULA; PULMONARY HYPERTENSION; RESPIRATORY TRACT DISEASE; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; SLEEP APNEA SYNDROME; THORAX SURGERY; TRAFFIC SAFETY; TUBERCULOSIS; UNITED KINGDOM; VALVULAR HEART DISEASE; VENOUS THROMBOEMBOLISM; ADULT; AEROSPACE MEDICINE; AIRCRAFT; ARTICLE; ATMOSPHERIC PRESSURE; CARDIOVASCULAR DISEASE; CHILD; FITNESS; INFANT; INFECTION; LUNG DISEASE; LUNG FUNCTION TEST; NEBULIZER; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RISK ASSESSMENT; RISK FACTOR; TRAVEL; TREATMENT OUTCOME;

ADULT; AEROSPACE MEDICINE; AIRCRAFT; ALTITUDE; ASTHMA; ATMOSPHERIC PRESSURE; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; COMORBIDITY; EVIDENCE-BASED MEDICINE; GREAT BRITAIN; HUMANS; INFANT; INFECTION; LUNG DISEASES; NEBULIZERS AND VAPORIZERS; OXYGEN; PHYSICAL FITNESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; RISK FACTORS; SOCIETIES, MEDICAL; TRAVEL; TREATMENT OUTCOME;

EID: 80054822682     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2011-200295     Document Type: Review

References (252)

1. Coker RK, Boldy DAR, Buchdahl R, et al. Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations. Thorax 2002;57:289-304.
2. Coker RK, Boldy DAR, Buchdahl R, et al. Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations (web-based update), 2004. http://www.brit-thoracic.org.uk/.
3. Schwartz JS, Bencowitz HZ, Moser KM. Air travel hypoxemia with chronic obstructive pulmonary disease. Ann Intern Med 1984;100:473-7. (Pubitemid 14131399)
4. Robson AG, Hartung TK, Innes JA. Laboratory assessment of fitness to fly in patients with lung disease: a practical approach. Eur Respir J 2000;16:214-19. (Pubitemid 30624938)
5. Christensen CC, Ryg M, Refvem OK, et al. Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2,438m (8,000 ft) altitude. Eur Respir J 2000;15:635-9. (Pubitemid 30196288)
6. Coker RK, Shiner RJ, Partridge MR. Is air travel safe for those with lung disease? Eur Respir J 2007;30:1057-63. (Pubitemid 351194750)
7. Akerø A, Christensen CC, Edvardsen A, et al. Pulse oximetry in the preflight evaluation of patients with chronic obstructive pulmonary disease. Aviat Space Environ Med 2008;79:518-24. (Pubitemid 351619958)
8. Civil Aviation Authority (CAA). http://www.caa.co.uk/.
9. International Aviation Transport Authority (IATA). Passenger numbers to reach 2.75 billion by 2011, 2007. http://www.iata.org/pressroom/pr/2007-24-10- 01.htm.
10. Iglesias R, Del Carmen Gonzalez C, Almanza C. Facing air passengers' medical problems while on board. Aerosp Med 1974;45:204-6.
11. Lee AP, Yamamoto LG, Relles NL. Commercial airline travel decreases oxygen saturation in children. Pediatr Emerg Care 2002;18:78-80. (Pubitemid 34327020)
12. Sand M, Bechara FG, Sand D, et al. Surgical and medical emergencies on board European aircraft: a retrospective study of 10189 cases. Crit Care 2009 13:R3.
13. Coker RK, Partridge MR. Assessing the risk for hypoxia in flight: the need for more rational guidelines. Eur Respir J 2000 15:128-30. (Pubitemid 30068948)
14. British Thoracic Society. Guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52:S1-28.
15. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995;8:1398-420.
16. Wedzicha JA. Domiciliary oxygen prescribing services. Clinical guidelines and advice for prescribers. Summary of a report of the Royal College of Physicians. J R Coll Physicians Lond 1999;33:445-7.
17. Anon. ATS statement: standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77-120.
18. Lien D, Turner MD. Recommendations for patients with chronic respiratory disease considering air travel: a statement from the Canadian Thoracic Society. Can Respir J 1998;5:95-100. (Pubitemid 28230228)
19. Cummin ARC, Nicholson AN. Aviation Medicine and the Airline Passenger. London: Hodder Arnold, 2002.
20. Aerospace Medical Association. Medical guidelines for air travel, 2nd edn. Aviat Space Environ Med 2003;74(Suppl 5):A1-19. http://www.asma.org/.
21. Aerospace Medical Association. Medical oxygen and air travel. Aviat Space Environ Med 2000;71:827-31.
22. Aerospace Medical Association. Inflight medical emergencies. Aviat Space Environ Med 2000;71:832-8.
23. Aerospace Medical Association, Air Transport Medicine Committee. Medical guidelines for air travel. Aviat Space Environ Med 1996;67:B1-16.
24. Fletcher CM, Elmes PC, Fairbairn MB, et al. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. BMJ 1959;2:257-66.
25. Resnick SM, Hall GL, Suimmer KN, et al. The hypoxia challenge test does not accurately predict hypoxia in flight in ex-preterm neonates. Chest 2008;133:1161-6. (Pubitemid 351685521)
26. FAA and European regulations JAR-OPS AMC 1.755 Emergency Medical Kit.
27. Cates CJ. Holding Chambers versus Nebulisers for Beta Agonist Treatment of Acute Asthma. (Cochrane Review). The Cochrane Library 1999; Issue 3. Oxford: Update Software, 1999.
28. Poundstone W. Air travel and supplementary oxygen: friendly skies for respiratory patients? Respir Ther 1983;13:79-82.
29. Dowdall N. 'Is there a doctor on the aircraft?' Top in-flight medical emergencies. BMJ 2000;321:1336-7.
30. Smith D, Toff W, Joy M, et al. Fitness to fly for passengers with cardiovascular disease. Heart 2010;96:ii1-16.
31. Levine BD, Zuckerman JH, deFilippi CR. Effect of high-altitude exposure in the elderly: the Tenth Mountain Division Study. Circulation 1997;96:1224-32. (Pubitemid 27344227)
32. World Health Organization. Tuberculosis and Air Travel: Guidelines for Prevention and Control. 3rd edn. WHO/HTM/TB/2008.399. http://www.who.int/tb/ features-archive/aviation-guidelines/en/.
33. Geretti AM. British HIV Association guidelines for immunization of HIV-infected adults 2008. HIV Med 2008;9:795-848.
34. Nunn JF. Applied Respiratory Physiology. 3rd edn. London: Butterworths, 1987:312.
35. Code of Federal Regulations. Title 14, part 25.841. Washington: US Government Printing Office, 1986.
36. Hunt EH, Reid DH, Space DR, et al. Commercial Airliner Environmental Control System Engineering Aspects of Cabin Air Quality. Aerospace Medical Association Annual Meeting Anaheim, California, May 1995.
37. Seccombe LM, Peters MJ. Oxygen supplementation for chronic obstructive pulmonary disease patients during air travel. Curr Opin Pulm Med 2006;12:140-4. (Pubitemid 44384789)
38. Cottrell JJ. Altitude exposure during aircraft flight. Chest 1988;92:81-4.
39. Muhm JM, Rock PB, McMullin DL, Jones SP, et al. Effect of aircraft-cabin altitude on passenger discomfort. N Engl J Med 2007;357:18-27. (Pubitemid 47026731)
40. Butland RJ, Pang J, Gross ER, et al. Two, six, and 12 minute walking tests in respiratory disease. BMJ 1982;284:1607-8. (Pubitemid 12105148)
41. McGavin CR, Gupta SP, McHardy GJ. Twelve minute walking test for assessing disability in chronic bronchitis. BMJ 1976;1:822-3.
42. Revill SM, Morgan MD, Singh SJ, et al. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 1999;54:213-22. (Pubitemid 29110500)
43. Apte NM, Karnad DR. Altitude hypoxaemia and the arterial-to-alveolar oxygen ratio. Ann Intern Med 1990;112:547-8. (Pubitemid 20100295)
44. Dillard TA, Rosenberg AP, Berg BW. Hypoxaemia during altitude exposure. A meta-analysis of chronic obstructive pulmonary disease. Chest 1993;103:422-5. (Pubitemid 23070738)
45. Dillard TA, Berg BW, Rajagopal KR, et al. Hypoxaemia during air travel in patients with COPD. Ann Intern Med 1989;111:362-7.
46. Gong H, Tashkin DP, Lee EY, et al. Hypoxia-altitude simulation test. Am Rev Respir Dis 1984;130:980-6.
47. Henry JN, Krenis LJ, Cutting RT. Hypoxaemia during aeromedical evacuation. Surg Gynecol Obstet 1973;136:49-53.
48. Dillard TA, Moores LK, Bilello KL, et al. The preflight evaluation. A comparison of the hypoxia inhalation test with hypobaric exposure. Chest 1995;107:352-7.
49. Cramer D, Ward S, Geddes D. Assessment of oxygen supplementation during air travel. Thorax 1996;51:202-3. (Pubitemid 26058158)
50. Vohra KP, Klocke RA. Detection and correction of hypoxemia associated with air travel. Am Rev Respir Dis 1993;148:1215-19. (Pubitemid 23326016)
51. Robson AG, Lenney J, Innes JA. Using laboratory measurements to predict inflight desaturation in respiratory patients: are current guidelines appropriate? Respir Med 2008;102:1592-7.
52. Kelly PT, Swanney MP, Stanton JD, et al. Resting and exercise response to altitude in patients with chronic obstructive pulmonary disease. Aviat Space Environ Med 2009;80:102-7.
53. Akerø A, Christensen CC, Edvardsen A, et al. Hypoxaemia in chronic obstructive pulmonary disease patients during a commercial flight. Eur Respir J 2005;25:725-30. (Pubitemid 40528769)
54. Akerø A, Edvardsen A, Christensen CC, et al. COPD and air travel: oxygen equipment and pre-flight titration of supplemental oxygen. Chest. Published Online First: 11 November 2010. doi:10.1378 chest.10-0965.
55. Moore BR, Ping JM, Claypool DW. Pediatric emergencies on a US-based commercial airline. Pediatr Emerg Care 2005;21:725-9. (Pubitemid 41689563)
56. Bossley C, Balfour-Lyn IM. Taking young children on aeroplanes: what are the risks? Arch Dis Child 2008;93:528-33. (Pubitemid 352025773)
57. Community Paediatrics Committee, Canadian Paediatric Society. Air travel and children's health issues. Paediatr Child Health 2007;12:45-50.
58. Lanteri CJ, Sly PD. Changes in respiratory mechanics with age. J Appl Physiol 1993;74:369-78. (Pubitemid 23059770)
59. Greenough A. Neonatal pulmonary physiology. In: Rennie JM, Roberton NRC, eds. Textbook of Neonatology. 3rd edn. Edinburgh, London: Churchill Livingstone, 1999:455-81.
60. Letsky EA. Anaemia in the newborn. In: Rennie JM, Roberton NRC, eds. Textbook of Neonatology. 3rd edn. Edinburgh, London: Churchill Livingstone, 1999:806-33.
61. Parkins KJ, Poets CF, O'Brien LM, et al. Effect of exposure on breathing patterns and oxygen saturation in infants: interventional study. BMJ 1998;316:887-94.
62. Oades PJ, Buchdahl RM, Bush A. Prediction of hypoxaemia at high altitude in children with cystic fibrosis. BMJ 1994;308:15-18. (Pubitemid 24048997)
63. Buchdahl RM, Babiker A, Bush A, et al. Predicting hypoxaemia during flights in children with cystic fibrosis. Thorax 2001;56:877-9. (Pubitemid 32999837)
64. Buchdahl R, Bush A, Ward S, et al. Pre-flight hypoxic challenge in infants and young children with respiratory disease (letter). Thorax 2004;59:1001-2.
65. Udomittipong K, Stick SM, Verheggen M, et al. Pre-flight testing of preterm infants with neonatal lung disease: a retrospective review. Thorax 2006;61:343-7.
66. Martin AC, Verheggen M, Stick SM, et al. Definition of cut-off values for the hypoxia test used for pre-flight testing in young children with neonatal chronic lung disease. Chest 2008;133:914-19. (Pubitemid 351536866)
67. Hall GL, Verheggen M, Stick SM. Assessing fitness to fly in young infants and children (letter). Thorax 2007;62:278-9. (Pubitemid 46579816)
68. Balfour-Lynn IM, Field DJ, Gringras P, et al. British Thoracic Society guidelines for home oxygen in children. Thorax 2009;64 (Suppl II):1-26.
69. Belcher E, Lawson MH, Nicholson AG, et al. Congenital cystic adenomatoid malformation presenting as in-flight systemic air embolisation. Eur Respir J 2007;30:801-4. (Pubitemid 351194842)
70. Church NR, Anas NG, Hall CB, et al. Respiratory syncytial virus-related apnea in infants. Demographics and outcome. Am J Dis Child 1984;138:247-50. (Pubitemid 14190045)
71. Bruhn FW, Mokrohisky ST, McIntosh K. Apnea associated with respiratory syncytial virus infection in young infants. J Pediatr 1977;3:382-6. (Pubitemid 8052223)
72. Green A. International travel and disease: epidemiology, regulation, and prevention. In: Ernsting J, Nicholson AN, Rainford DJ, eds. Aviation Medicine. 3rd edn. London: Arnold MO Hodder Headline Group, 1999:385-96.
73. Moser MR, Bender TR, Margolis HS, et al. An outbreak of influenza aboard a commercial airliner. Am J Epidemiol 1979;110:1-6. (Pubitemid 10207328)
74. Kenyon TA, Valway SE, Ihle WW, et al. Transmission of a multidrug-resistant Mycobacterium tuberculosis during a long airplane flight. N Engl J Med 1996;334:933-8. (Pubitemid 26114158)
75. Berntsen S, Stensrud T, Ingjer F, et al. Asthma in medium altitude exercise-induced bronchoconstriction in subjects with asthma. Allergy 2005;60:1308-11. (Pubitemid 41297528)
76. Louie D, Pare PD. Physiological changes at altitude in non-asthmatic and asthmatic subjects. Can Respir J 2004;11:197-9. (Pubitemid 38735505)
77. Golan Y, Onn A, Villa Y, et al. Asthma in adventure travellers: a prospective study evaluating the occurrence and risk factors for acute exacerbations. Arch Intern Med 2002;162:2421-6. (Pubitemid 35340457)
78. Cummins RO, Schubach JA. Frequency and types of medical emergencies among commercial air travellers. JAMA 1989;261:1295-9. (Pubitemid 19072221)
79. Delaune EF III, Lucas RH, Illig P. In-flight medical events and aircraft diversions: one airline's experience. Aviat Space Environ Med 2003;74:62-8. (Pubitemid 36055671)
80. Donaldson E, Pearn J. First aid in the air. Aust NZ J Surg 1996;66:431-4. (Pubitemid 26251744)
81. Szmajer M, Rodriguez P, Sauval P, et al. Medical assistance during commercial airline flights: analysis of 11 years experience of the Paris emergency medical service (SAMU) between 1989 and 1999. Resuscitation 2001;50:147-51. (Pubitemid 32823451)
82. Cottrell JJ, Callaghan JT, Kohn GM, et al. In-flight medical emergencies. One year of experience with the enhanced medical kit. JAMA 1989;262:1653-6. (Pubitemid 19233520)
83. Noel AA. Medical events during airline flights. N Engl J Med 2002;347:535-7.
84. Qureshi A, Porter KM. Emergencies in the air. Emerg Med J 2005;22:658-9. http://www.boeing.com/commercial/cabinair/ecs.pdf (accessed Feb 2009). (Pubitemid 41200640)
85. Gong H. Air travel and oxygen therapy in cardiopulmonary patients. Chest 1992;101:1104-13.
86. Mortazavi A, Eisenberg MJ, Langleben D, et al. Altitude-related hypoxia: risk assessment and management for passengers on commercial aircraft. Aviat Space Environ Med 2003;74:922-7. (Pubitemid 37082337)
87. Dillard TA, Rajagopal KR, Slivka WA, et al. Lung function during moderate hypobaric hypoxia in normal subjects and patients with chronic obstructive pulmonary disease. Aviat Space Environ Med 1998;69:979-85.
88. Berg BW, Dillard TA, Derderian SS, et al. Hemodynamic effects of altitude exposure and oxygen administration in chronic obstructive pulmonary disease. Am J Med 1993;94:407-12. (Pubitemid 23106628)
89. Chetta A, Castagnetti C, Aiello M, et al. Walking capacity and fitness to fly in patients with chronic respiratory disease. Aviat Space Environ Med 2007;78:789-92. (Pubitemid 47264794)
90. Martin SE, Bradley JM, Buick JB, et al. Flight assessment in patients with respiratory disease: hypoxic challenge testing vs. predictive equations. QJM 2007;100:361-7. (Pubitemid 47073812)
91. Berg BW, Dillard TA, Rajagopal KR, et al. Oxygen supplementation during air travel in patients with chronic obstructive lung disease. Chest 1992;101:638-41.
92. Kelly PT, Swanney MP, Seccombe LM, et al. Air travel hypoxemia vs the hypoxia inhalation test in passengers with COPD. Chest 2008;133:920-6. (Pubitemid 351536867)
93. Kramer MR, Jakobson DJ, Springer C, et al. The safety of air transportation of patients with advanced lung disease. Chest 1995;108:1292-6.
94. GOLD. Global initiative for chronic obstructive lung disease: spirometric classification of COPD severity. http://www.goldcopd.com/.
95. Dillard TA, Beninati WA, Berg BW. Air travel in patients with chronic obstructive pulmonary disease. Arch Intern Med 1991;151:1793-5.
96. Edvardsen A, Akerø A, Hardie JA, et al. High prevalence of respiratory symptoms during air travel in patients with COPD. Respir Med 2011;105:50-6.
97. Peckham D, Watson A, Pollard K, et al. Predictors of desaturation during formal hypoxic challenge in adult patients with cystic fibrosis. J Cyst Fibros 2002;1:281-6.
98. Fischer R, Lang SM, Bruckner K, et al. Lung function in adults with cystic fibrosis at altitude: impact on air travel. Eur Respir J 2005;25:718-24. (Pubitemid 40528768)
99. Rose DM, Fleck B, Thews O. Blood gas analyses in patients with cystic fibrosis to estimate hypoxaemia during exposure to high altitudes in a hypobaric chamber. Eur J Med Res 2000;5:9-12.
100. Kamin W, Fleck B, Rose DM. Predicting hypoxia in cystic fibrosis patients during exposure to high altitudes. J Cyst Fibros 2006;5:223-8. (Pubitemid 44824856)
101. Bartsch P, Gibbs JS. Effect of altitude on the heart and the lungs. Circulation 2007;116:2191-202. (Pubitemid 350060357)
102. Vita JA, Keaney JF Jr. Exercise-toning up the endothelium? N Engl J Med 2000;342:503-5.
103. Wyss CA, Koepfli P, Fretz G, et al. Influence of altitude exposure on coronary flow reserve. Circulation 2003;108:1202-7. (Pubitemid 37099988)
104. De Luca G, Suryapranata H, van't Hof AWJ, et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty. Implications for early discharge. Circulation 2004;109:2737-43. (Pubitemid 38737921)
105. Task Force of the European Society of Cardiology. Guideline for the diagnosis and treatment of non ST elevation acute coronary syndromes. Eur Heart J 2007;28:1598-660.
106. Anon. Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland. Thorax 2008;63(Suppl 2):ii1-41.
107. Broberg CS, Uebing A, Cuomo L, et al. Adult patients with Eisenmenger syndrome report flying safely on commercial airlines. Heart 2007;93:1599-603. (Pubitemid 350205558)
108. Harinck E, Hutter PA, Hoorntje TM, et al. Air travel and adults with cyanotic congenital heart disease. Circulation 1996;93:272-6. (Pubitemid 26031485)
109. Waldman JD, Lamberti JJ, Mathewson JW, et al. Congenital heart disease and pulmonary artery hypertension. I. Pulmonary vasoreactivity to 15% oxygen before and after surgery. J Am Coll Cardiol 1983;2:1158-64. (Pubitemid 14249600)
110. Agostoni P, Cattadori G, Guazzi M, et al. Effects of simulated altitude-induced hypoxia on exercise capacity in patients with chronic heart failure. Am J Med 2000;109:450-5.
111. Podrid PJ, Fuchs T, Candinas R. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation 1990;82:103-13.
112. Skipworth RA, Puthucheary Z, Raptis DA, et al. The effect of acute hypoxia on QTc interval in respiratory patients undergoing fitness to fly tests. Thorax. Published Online First: 22 October 2010. doi:10.1136/thx.2010.151712.
113. Somers VK, Mark AL, Abboud FM. Potentiation of sympathetic nerve responses to hypoxia in borderline hypertensive subjects. Hypertension 1988;11:608-12.
114. Gardner WN. The pathophysiology of hyperventilation disorders. Chest 1996;109:516-34. (Pubitemid 26058614)
115. Gibson TM. Hyperventilation in flight. Aviat Space Environ Med 1984;55:412-14.
116. Gibson TM. Hyperventilation in aircrew: a review. Aviat Space Environ Med 1979;50:725-33. (Pubitemid 9222295)
117. Balke B, Wells JG, Clark RT. In-flight hyperventilation in aircraft pilots. J Aviat Med 1957;28:241-8.
118. Harding RM, Mills FJ. Aviation medicine. Problems of altitude: I. Hypoxia and hyperventilation. BMJ (Clin Res Ed) 1983;286:1408-10. (Pubitemid 13128636)
119. Cowey DS, Roy-Byrne PP. Hyperventilation and apnoeic disorder. Am J Med 1987;83:929-37.
120. Matsumoto K, Goebert D. In-flight psychiatric emergencies. Aviat Space Environ Med 2001;72:919-23. (Pubitemid 32952629)
121. Lewis RA, Howells JB. Definition of the hyperventilation syndrome. Bull Eur Physiopathol Respir 1985;2:201-5.
122. van Dixhoorn J. Hyperventilation and dysfunctional breathing. Biol Psychol 1997;46:90-1.
123. Hornsveld HK, Garssen B. Double-blind placebo controlled study of the hyperventilation provocation test and the validity of the hyperventilation syndrome. Lancet 1996;384:154-8. (Pubitemid 26238098)
124. Han JN, Stengen K, Valck De, et al. Influence of breathing therapy on complaints, anxiety and breathing pattern in patients with hyperventilation syndrome and anxiety disorders. J Psychosom Res 1996;5:481-93. (Pubitemid 27032770)
125. Salkovskis PM, Jones D, Clark D. Respiratory control in the treatment of panic attacks. replication and extension with concurrent measurement of behaviour and pCO2. Br J Psychiatry 1985;148:526-32. (Pubitemid 16042298)
126. Brown TP, Shuker LK, Rushton L, et al. The possible effects on health, comfort and safety of aircraft cabin environments. J R Soc Promot Health 2001;121:177-84. (Pubitemid 32952006)
127. Rayman RB. Cabin air quality: an overview. Aviat Space Environ Med 2002;73:211-15. (Pubitemid 34195147)
128. DeHart RL. Health issues of air travel. Annu Rev Public Health 2003;24:133-51. (Pubitemid 37056027)
129. Leder K, Newman D. Respiratory infections during air travel. Intern Med J 2005;35:50-5. (Pubitemid 40254768)
130. Rayman RB. Passenger safety, health, and comfort: a review. Aviat Space Environ Med 1997;68:432-40. (Pubitemid 27194012)
131. Mangili A, Gendreau MA. Transmission of infectious diseases during commercial air travel. Lancet 2005;365:989-96. (Pubitemid 41071434)
132. Wenzel RP. Airline travel and infection. N Engl J Med 1996;334:981-2. (Pubitemid 26114166)
133. Dechow M, Sohn H, Steinhanses J. Concentrations of selected contaminants in cabin air of airbus aircrafts. Chemosphere 1997;35:21-31. (Pubitemid 27308115)
134. Harding R. Cabin air quality in aircraft. BMJ 1994;308:427-8.
135. Wick RL, Irvine LA. The microbiological composition of airliner cabin air. Aviat Space Environ Med 1995;66:220-4.
136. Rydock JP. Tracer study of proximity and recirculation effects on exposure risk in an airliner cabin. Aviat Space Environ Med 2004;75:168-71. (Pubitemid 38133884)
137. Valway SE, Sanchez MP, Shinnick TF, et al. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N Engl J Med 1998;338:633-9. (Pubitemid 28108432)
138. Byrne N. Low prevalence of TB on long-haul aircraft. Travel Med Infect Dis 2007;5:18-23. (Pubitemid 44856487)
139. Abubakar I, Welfare R, Moore J, et al. Surveillance of air travel-related tuberculosis incidents, England and Wales: 2007-2008. Euro Surveill 2008;13(23):pii: 18896.
140. Center for Disease Control and Prevention (CDC). Exposure of passengers and flight crew to Mycobacterium tuberculosis on commercial aircraft, 1992-1995. MMWR Morb Mortal Wkly Rep 1995;44:137-40.
141. Driver CR, Valway SE, Morgan WM, et al. Transmission of Mycobacterium tuberculosis associated with air travel. JAMA 1994;272:1031-5. (Pubitemid 24294654)
142. McFarland JW, Hickman C, Osterholm M, et al. Exposure to Mycobacterium tuberculosis during air travel. Lancet 1993;342:112-13. (Pubitemid 23192432)
143. Miller MA, Valway S, Onorato IM. Tuberculosis risk after exposure on airplanes. Tuberc Lung Dis 1996;77:414-19. (Pubitemid 26390468)
144. Moore M, Valway SE, Ihle W, et al. A train passenger with pulmonary tuberculosis: evidence of limited transmission during travel. Clin Infect Dis 1999;28:52-6. (Pubitemid 29246125)
145. Nardell EA, Keegan J, Cheney SA, et al. Airborne infection. Theoretical limits of protection achievable by building ventilation. Am Rev Respir Dis 1991;144:302-6.
146. Moore M, Fleming KS, Sands L. A passenger with pulmonary/laryngeal tuberculosis: no evidence of transmission on two short flights. Aviat Space Environ Med 1996;67:1097-100. (Pubitemid 26372511)
147. Parmet AJ. Tuberculosis on the flight deck. Aviat Space Environ Med 1999;70:817-18. (Pubitemid 29357708)
148. Wang PD. Two-step tuberculin testing of passengers and crew on a commercial airplane. Am J Infect Control 2000;28:233-8. (Pubitemid 30397519)
149. Whitlock G, Calder L, Perry H. A case of infectious tuberculosis on two long-haul aircraft flights: contact investigation. NZ Med J 2001;114:353-5. (Pubitemid 33607911)
150. Chemardin J, Paty MC, Renard-Dubois S, et al. Contact tracing of passengers exposed to an extensively drug-resistant tuberculosis case during an air flight from Beirut to Paris, October 2006. Euro Surveill 2007;12:E071206.2.
151. Martinez L, Blanc L, Nunn P, et al. Tuberculosis and air travel: WHO guidance in the era of drug-resistant TB. Travel Med Infect Dis 2008;6:177-81. (Pubitemid 351835173)
152. Markel H, Gostin LO, Fidler DP. Extensively drug-resistant tuberculosis: an isolation order, public health powers, and a global crisis. JAMA 2007;298:83-86. (Pubitemid 47028534)
153. Jones RM, Masago Y, Bartrand T, et al. Characterizing the risk of infection from Mycobacterium tuberculosis in commercial passenger aircraft using quantitative microbial risk assessment. Risk Anal 2009;29:355-65.
154. Ko G, Thompson KM, Nardell EA. Estimation of tuberculosis risk on a commercial airliner. Risk Anal 2004;24:379-88. (Pubitemid 38620135)
155. Vassiloyanakopoulos A, Spala G, Mavrou E, et al. A case of tuberculosis on a long distance flight: the difficulties of the investigation. Euro Surveill 1999;4:96-7.
156. Grais RF, Ellis JH, Kress A, et al. Modeling the spread of annual influenza epidemics in the U.S.: the potential role of air travel. Health Care Manag Sci 2004;7:127-34. (Pubitemid 39024056)
157. Grais RF, Ellis JH, Glass GE. Assessing the impact of airline travel on the geographic spread of pandemic influenza. Eur J Epidemiol 2003;18:1065-72. (Pubitemid 37339371)
158. Hufnagel L, Brockmann D, Geisel T. Forecast and control of epidemics in a globalized world. Proc Natl Acad Sci U S A 2004;101:15124-9. (Pubitemid 39391729)
159. Flahault A, Deguen S, Valleron AJ. A mathematical model for the European spread of influenza. Eur J Epidemiol 1994;10:471-4. (Pubitemid 24339218)
160. Brownstein JS, Wolfe CJ, Mandl KD. Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States. PLoS Med 2006;3:e401.
161. Colizza V, Barrat A, Barthelemy M, et al. Modeling the worldwide spread of pandemic influenza: baseline case and containment interventions. PLoS Med 2007;4:e13.
162. Hollingsworth TD, Ferguson NM, Anderson RM. Will travel restrictions control the international spread of pandemic influenza? Nat Med 2006;12:497-9.
163. Degli Atti MLC, Merler S, Rizzo C, et al. Mitigation measures for pandemic influenza in Italy: an individual based model considering different scenarios. PLoS ONE 2008;3:e1790.
164. Flahault A, Vergu E, Coudeville L, et al. Strategies for containing a global influenza pandemic. Vaccine 2006;24:6751-5. (Pubitemid 46107158)
165. Epstein JM, Goedecke DM, Yu F, et al. Controlling pandemic flu: the value of international air travel restrictions. PLoS ONE 2007;2:e401.
166. Evans A, Finkelstein S, Singh J, et al. Pandemic influenza: a note on international planning to reduce the risk from air transport. Aviat Space Environ Med 2006;77:974-6. (Pubitemid 44320448)
167. McLeod MA, Baker M, Wilson N, et al. Protective effect of maritime quarantine in South Pacific jurisdictions, 1918-19 influenza pandemic. Emerg Infect Dis 2008;14:468-70. (Pubitemid 351451397)
168. Nishiura H, Wilson N, Baker MG. Quarantine for pandemic influenza control at the borders of small island nations. BMC Infect Dis 2009;9:27.
169. Bell DM; WHO Writing Group. Non-pharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis 2006;12:81-7.
170. Sato K, Morishita T, Nobusawa E, et al. Surveillance of influenza viruses isolated from travellers at Nagoya International Airport. Epidemiol Infect 2000;124:507-14. (Pubitemid 30623868)
171. Laurel VL, Witt CCD, Geddie YA, et al. An outbreak of influenza a caused by imported virus in the United States, July 1999. Clin Infect Dis 2001;32:1639-42. (Pubitemid 32458735)
172. Klontz KC, Hynes NA, Gunn RA, et al. An outbreak of influenza A/Taiwan/1/86 (H1N1) infections at a naval base and its association with airplane travel. Am J Epidemiol 1989;129:341-8. (Pubitemid 19046999)
173. Marsden AG. Outbreak of influenza-like illness [corrected] related to air travel. Med J Aust 2003;179:172-3. (Pubitemid 37025201)
174. Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003;361:1761-6. (Pubitemid 36638422)
175. Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-6.
176. WHO Multicentre Collaborative Network for SARS Diagnosis. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet 2003;361:1730-3.
177. Wilder-Smith A, Leong HN, Villacian JS. In-flight transmission of severe acute respiratory syndrome (SARS): a case report. J Travel Med 2003;10:299-300. (Pubitemid 37280034)
178. Desenclos JC, van der Werf S, Bonmarin I, et al. Introduction of SARS in France, March-April 2003. Emerg Infect Dis 2004;10:195-200. (Pubitemid 38176954)
179. Wilder-Smith A, Paton NI. Severe acute respiratory syndrome: imported cases of severe acute respiratory syndrome to Singapore had impact on national epidemic. BMJ 2003;326:1393-4.
180. Olsen SJ, Chang HL, Cheung TYY, et al. Transmission of the severe acute respiratory syndrome on aircraft. N Engl J Med 2003;349:2416-22. (Pubitemid 37542990)
181. Wilder-Smith A, Paton NI, Goh KT. Low risk of transmission of severe acute respiratory syndrome on airplanes: the Singapore experience. Trop Med Int Health 2003;8:1035-7. (Pubitemid 37386473)
182. Breugelmans JG, Zucs P, Porten K, et al. SARS transmission and commercial aircraft. Emerg Infect Dis 2004;10:1502-3.
183. Flint J, Burton S, Macey JF, et al. Assessment of in-flight transmission of SARS: results of contact tracing, Canada. Can Commun Dis Rep 2003;29:105-10.
184. Lindgren T, Norbäck D, Andersson K, et al. Cabin environment and perception of cabin air quality among commercial aircrew. Aviat Space Environ Med 2000;71:774-82. (Pubitemid 30614806)
185. Norbäck D, Lindgren T, Wieslander G. Changes in ocular and nasal signs and symptoms among air crew in relation to air humidification on intercontinental flights. Scand J Work Environ Health 2006;32:138-44. (Pubitemid 43676821)
186. de Souza Luna LK, Panning M, Grywna K, et al. Spectrum of viruses and atypical bacteria in intercontinental air travellers with symptoms of acute respiratory infection. J Infect Dis 2007;195:675-9.
187. Singh B. Sickness pattern among air travellers: review of 735 cases at the Oman airport. Aviat Space Environ Med 2002;73:684-7. (Pubitemid 34701165)
188. Zitter JN, Mazonson PD, Miller DP, et al. Aircraft cabin air recirculation and symptoms of the common cold. JAMA 2002;288:483-6. (Pubitemid 34787480)
189. Whelan EA, Lawson CC, Grajewski B, et al. Prevalence of respiratory symptoms among female flight attendants and teachers. Occup Environ Med 2003;60:929-34. (Pubitemid 37494579)
190. Hargarten SW, Bouc GT. Emergency air medical transport of U.S.-citizen
191. Ansart S, Pajot O, Grivois JP, et al. Pneumonia among travelers returning from abroad. J Travel Med 2004;11:87-91. (Pubitemid 38523681)
192. Gong H, Mark JA, Cowan MN. Preflight medical screenings of patients. Analysis of health and flight characteristics. Chest 1993;104:788-94. (Pubitemid 23268949)
193. World Health Organization. Travel by air: health considerations. Wkly Epidemiol Rec 2005;80:181-91.
194. Espinal MA, Peréz EN, Baéz J, et al. Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study. Lancet 2000;355:275-80. (Pubitemid 30068520)
195. Cruciani M, Malena M, Bosco O, et al. The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: a meta-analysis. Clin Infect Dis 2001;33:1922-30. (Pubitemid 33105135)
196. Nunn P, Mungai M, Nyamwaya J, et al. The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis. Tuberc Lung Dis 1994;75:25-32. (Pubitemid 24128756)
197. Elliott AM, Hayes RJ, Halwiindi B, et al. The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia. AIDS 1993;7:981-7. (Pubitemid 23239673)
198. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-50. (Pubitemid 19070537)
199. Di Perri G, Cruciani M, Danzi MC, et al. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet 1989;2:1502-4. (Pubitemid 20018152)
200. Barnes PF, Bloch AB, Davidson PT, et al. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991;324:1644-50.
201. Christensen CC, Ryg MS, Refvem OK, et al. Effect of hypobaric hypoxia on blood gases in patients with restrictive lung disease. Eur Respir J 2002;20:300-5.
202. Seccombe LM, Kelly PT, Wong CK, et al. Effect of simulated commercial flight on oxygenation in patients with interstitial lung disease and chronic obstructive pulmonary disease. Thorax 2004;59:966-70. (Pubitemid 39490782)
203. Vazquez J-C, Perez-Padilla R. Effect of oxygen on sleep and breathing in patients with interstitial lung disease at moderate altitude. Respiration 2001;68:584-9. (Pubitemid 34062930)
204. Noble JS, Davidson JA. Cor pulmonale presenting in a patient with congenital kyphoscoliosis following intercontinental air travel. Anaesthesia 1999;54:361-3. (Pubitemid 29155005)
205. Mestry N, Thirumaran M, Tuggey JM, et al. Hypoxic challenge flight assessments in patients with severe chest wall deformity or neuromuscular disease at risk for nocturnal hypoventilation. Thorax 2009;64:532-4.
206. Issa FG, Sullivan CE. Alcohol, snoring and sleep apnea. J Neurol Neurosurg Psychiatry 1982;45:353-9.
207. Liistro G, Aubert G, Rodenstein DO. Management of sleep apnoea syndrome. Eur Respir J 1995;8:1751-5.
208. Kribbs NB, Pack AI, Kline LR, et al. Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea. Am Rev Respir Dis 1993;147:1162-8. (Pubitemid 23149873)
209. Banerjee D, Yee B, Grunstein R. Airline acceptability of in-flight CPAP machines - flight, fright, or fight? Sleep 2003;26:914-15.
210. Toff NJ. Hazards of air travel for the obese. Miss Pickwick and the Boeing 747. J R Coll Physicians Lond 1993;27:375-6.
211. Massard G, Thomas P, Wihlm JM. Minimally invasive management for first and recurrent pneumothorax. Ann Thorac Surg 1998;11:354-61.
212. Delaunois L.el Khawand C. Medical thoracoscopy in the management of pneumothorax. Monaldi Arch Chest Dis 1998;53:148-50. (Pubitemid 28383184)
213. Almind M, Lange P, Viskum K. Spontaneous pneumothorax: comparison of simple drainage, talc pleurodesis and tetracycline pleurodesis. Thorax 1989;44:627-30. (Pubitemid 19197231)
214. Liu HP, Lin PG, Hsieh MG, et al. Thoracoscopic surgery as a routine procedure for spontaneous pneumothorax. Results from 82 patients. Chest 1995;107:559-62.
215. Barker A, Maratos EC, Edmonds L, et al. Recurrence rates of video-assisted thoracoscopic versus open surgery in the prevention of recurrent pneumothoraces: a systematic review of randomised and non-randomised trials. Lancet 2007;370:329-35. (Pubitemid 47094994)
216. Olsen PS, Andersen HO. Long term results after tetracycline pleurodesis in spontaneous pneumothorax. Ann Thorac Surg 1992;53:1015-17.
217. Alfagaeme I, Moreno L, Huertas C, et al. Spontaneous pneumothorax. Long term results with tetracycline pleurodesis. Chest 1994;106:347-50. (Pubitemid 24252023)
218. Sadikot RT, Greene T, Meadows K, et al. Recurrence of primary spontaneous pneumothorax. Thorax 1997;52:805-9. (Pubitemid 27412561)
219. Lippert HL, Lund O, Blegvade S, et al. Independent risk factors for cumulative recurrence rate after first spontaneous pneumothorax. Eur Respir J 1991;4:324-31.
220. Athanassiadi K, Kalavrouziotis G, Loutsidis A, et al. Surgical treatment of pneumothorax: 10 year experience. World J Surg 1998;22:803-6. (Pubitemid 28322075)
221. Janssen JP, Schramel FM, Sutedja TJ, et al. Video thorascopic appearance of first and recurrent pneumothorax. Chest 1995;108:330-4.
222. Cheatham ML, Safcsak K. Air travel following traumatic pneumothorax: when is it safe? Am Surg 1999;65:1160-4.
223. Currie GP, Kennedy AM, Paterson E, et al. A chronic pneumothorax and fitness to fly. Thorax 2007;62:187-9.
224. Pollock-BarZiv S, Cohen MM, Downey GP, et al. Air travel in women with lymphangioleiomyomatosis. Thorax 2007;62:176-80.
225. Shovlin CL, Jackson JE. Pulmonary arteriovenous malformations and other pulmonary vascular abnormalities. In: Murray and Nadel's Textbook of Respiratory Medicine. 5th edn. Pennsylvania: Elsiever-Saunders, 2010, pp 1261-82.
226. Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet 2009;17:8610-71.
227. Shovlin CL, Sulainam NL, Govani FS, et al. Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism. Thromb Haemost 2007;98:1031-9. (Pubitemid 350091132)
228. Shovlin CL, Jackson JE, Bamford K, et al. Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax 2008;63:259-66. (Pubitemid 351373723)
229. Weitzel EK, McMains KC, Rajapaksa S, et al. Aerosinusitis: pathophysiology, prophylaxis, and management in passengers and aircrew. Aviat Space Environ Med 2008;79:50-3.
230. Becker GD, Parell GJ. Barotrauma of the ears and sinuses after scuba diving. Eur Arch Otorhinolaryngol 2001;258:159-63. (Pubitemid 32467739)
231. Garges LM. Maxillary sinus barotrauma-case report and review. Aviat Space Environ Med 1985;56:796-802. (Pubitemid 15047748)
232. Segev Y, Landsberg R, Fliss DM. MR imaging appearance of frontal sinus barotrauma. Am J Neuroradiol 2003;24:346-7. (Pubitemid 36358983)
233. Jones JS, Sheffield W, White LJ, et al. A double-blind comparison between oral pseudophedrine and topical oxymetazoline in the prevention of barotrauma during air travel. Am J Emerg Med 1998;16:262-4. (Pubitemid 28217882)
234. Buchanan BJ, Hoagland J, Fischer PR. Pseudoephedrine and air travel-associated ear pain in children. Arch Pediatr Adolesc Med 1999;153:466-8. (Pubitemid 29220394)
235. Weiss MH, Frost JO. May children with otitis media with effusion travel safely? Clin Pediatr (Phila) 1987;26:567-8. (Pubitemid 18043639)
236. Smith JP, Furry DE. Aeromedical considerations in the management of paranasal sinus barotrauma. Aerosp Med 1972;43:1031-3.
237. O'Reilly BJ, McRae A, Lupa H. The role of functional endoscopic sinus surgery in the management of recurrent sinus barotrauma. Aviat Space Environ Med 1995;66:876-9.
238. World Health Organization. The WRIGHT Project: World Health Organization Research into Global Hazards of Travel. Geneva, Switzerland: WHO Press, 2007.
239. Scurr JH, Machin SJ, Bailey-King S, et al. Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial. Lancet 2001;357:1485-9. (Pubitemid 32488858)
240. Arfvidsson B. Risk factors for venous thromboembolism following prolonged air travel: a prospective study. Cardiovasc Surg 2001;9:158-9. (Pubitemid 32201462)
241. Hughes RJ, Hopkins RJ, Hill S, et al. Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study. Lancet 2003;362:2039-44. (Pubitemid 38032755)
242. Schwarz T, Langenberg K, Oettler W, et al. Deep vein and isolated calf muscle vein thrombosis following long-haul flights: pilot study. Blood Coagul Fibrinolysis 2002;13:755-7. (Pubitemid 36026834)
243. Schwarz T, Siegert G, Oettler W, et al. Venous thrombosis after long-haul flights. Arch Intern Med 2003;163:2759-64. (Pubitemid 37517417)
244. Lapostolle F, Surget V, Borron SW, et al. Severe pulmonary embolism associated with air travel. N Engl J Med 2001;345:779-83.
245. Lehmann R, Suess C, Leus M, et al. Incidence, clinical characteristics, and long-term prognosis of travel-associated pulmonary embolism. Eur Heart J 2009;30:233-41.
246. Toff WD, Jones CI, Ford I, et al. Effect of hypobaric hypoxia, simulating conditions during long-haul air travel, on coagulation, fibrinolysis, platelet function, and endothelial activation. JAMA 2006;295:2251-61. (Pubitemid 43736575)
247. Schreijer AJ, Cannegieter SC, Meijers JC, et al. Activation of coagulation system during air travel: a crossover study. Lancet 2006;367:832-8. (Pubitemid 43363370)
248. Cannegieter SC, Doggen CJ, van Houwelingen HC, et al. Travel-related venous thrombosis: results from a large population-based case control study (MEGA study). PLoS Med 2006;3:e307.
249. Paganin F, Bourde A, Yvin JL, et al. Venous thromboembolism in passengers following a 12-h flight: a case-control study. Aviat Space Environ Med 2003;74:1277-80. (Pubitemid 37523135)
250. Cesarone MR, Belcaro G, Nicolaides AN, et al. Venous thrombosis from air travel: the LONFLIT3 study-prevention with aspirin vs low-molecular-weight heparin (LMWH) in high-risk subjects: a randomized trial. Angiology 2002;53:1-6. (Pubitemid 34141884)
251. Anon. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000;355:1295-302.
252. Lurie F, Kistner RL, Eklof B, et al. Prevention of air travel-related deep venous thrombosis with mechanical devices: active foot movements produce similar hemodynamic effects. J Vasc Surg 2006;44:889-91. (Pubitemid 44441780)